Full-Time

Emerging Markets Lead

Montu

Montu

501-1,000 employees

End-to-end medical cannabis platform

Compensation Overview

£100k - £130k/yr

London, UK

Hybrid

Hybrid role based in London; requires international travel.

Category
Business & Strategy (2)
,
Required Skills
Market Research
Data Analysis

Get referred to Montu

See people who can refer or advise you

Requirements
  • A background in strategy or management consulting, with a track record of structured problem-solving delivered at pace
  • Experience in healthcare, healthtech or a related regulated industry is strongly preferred
  • A genuine willingness and ability to travel extensively - this role is not desk-bound and being out with partners and in-market is central to the job
  • Strong analytical and commercial instincts, with the ability to build a clear business case from a loose brief
  • Excellent stakeholder management skills, comfortable influencing senior internal and external audiences
  • A bias to action - equally happy building the strategy deck and then rolling up your sleeves to execute it
  • Highly self-motivated and comfortable operating autonomously in a fast-moving, scale-up environment where priorities can shift quickly
  • An interest in cannabis-based medicines and a genuine belief in improving patient access to modern healthcare treatments would be a bonus
  • Bonus points if you have also led market entry strategy to Poland.
Responsibilities
  • Own the end-to-end go-to-market strategy for new products, propositions and partnerships, from initial thesis through to launch and scale
  • Build the business cases, market sizing and prioritisation frameworks that determine where we play and how we win
  • Translate strategy into structured, actionable rollout plans with clear milestones, owners and KPIs
  • Travel internationally to build relationships with partners, pharmacies, clinicians and other key stakeholders on the ground
  • Work cross-functionally with Sales, Marketing, Product and Clinical teams to align on GTM priorities and remove blockers to execution
  • Represent Montu at industry events, partner meetings and in-market visits, acting as a credible face of the business
  • Track performance against launch plans, course-correcting quickly where results diverge from expectations
  • Bring an outside-in view of the market - competitor moves, regulatory shifts and emerging opportunities - back into the business
  • Present findings, plans and recommendations clearly and persuasively to senior leadership.
Desired Qualifications
  • An interest in cannabis-based medicines and a genuine belief in improving patient access to modern healthcare treatments would be a bonus
  • Bonus points if you have also led market entry strategy to Poland.

Montu is a health technology company focusing on Australia’s medical cannabis sector. It runs a vertically integrated system that covers the entire patient journey from telehealth consultations to medication delivery, including the Alternaleaf telehealth clinic, Leafio distribution, uMeds fulfillment, and its own portfolio of cannabis products. Alternaleaf connects patients with a large network of doctors and nurses for online consultations, after which a prescription can be issued and Montu handles the downstream supply chain to deliver the medicine. The company earns revenue from telehealth visits and product sales, and it differentiates itself through its integrated platform that combines production, prescription, and dispensing, though this model has drawn regulatory scrutiny. Montu’s goal is to expand access to medical cannabis in Australia and grow its platform and product offerings within the healthtech cannabis market.

Company Size

501-1,000

Company Stage

Early VC

Total Funding

$3.6M

Headquarters

Santiago, Chile

Founded

2019

Get referred to Montu

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Montu’s products page, updated July 13 2026, still calls it a leading supplier.
  • March 2026 Revelio data shows roughly 593 employees, despite 2026 headcount pressure.
  • May 2026 restructuring signals management is cutting costs and pushing digital patient workflows.

What critics are saying

  • The TGA’s April 2024 Federal Court case targets Montu, Alternaleaf, and Strauch.
  • June 2026 discovery allegations about deleted Slack and Miro files intensify penalties risk.
  • An adverse injunction or huge fine could cripple Alternaleaf’s advertising-led patient funnel.

What makes Montu unique

  • Alternaleaf, Leafio, and uMeds stitch consultation, dispensing, and distribution into one stack.
  • Montu told Parliament in April 2026 it serves over half Australia’s pharmacies.
  • Founder Christopher Strauch controls a vertically integrated medicinal-cannabis platform built since 2019.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Company Match

401(k) Retirement Plan

Cycle to work scheme

Company News

Cannabiz
Mar 4th, 2024
Company news: Montu; Vantage Hemp Co; InhaleRx

Montu has named former Pharmacy Guild of Australia national president George Tambassis as a special adviser.

Cannabiz
Sep 28th, 2023
Montu to launch Alternaleaf in the UK

Montu is launching online clinic Alternaleaf in the UK, headed up by local managing director Asif Dewan.

Cannabiz
Sep 22nd, 2023
Montu donates A$2 per patient to Pain Awareness Month

Montu has joined forces with Chronic Pain Australia (CPA) to promote Pain Awareness Month in a bid to raise A$100,000 for the cause.

Birchal
Apr 8th, 2023
Montu - Creating the future of cannabis

We are Montu. Our mission: Improve lives for millions of Australians through medical cannabis therapies.

The Australian Financial Review
Nov 22nd, 2020
Medicinal cannabis-related portal crowdfunds $2m

Montu will use the funds to boost its marketing and attract more doctors on to the platform to service patients who need cannabidiol-related treatments.